cnbc.com / .cnbc-com-health-care

The FDA sent 31 staffers to a Singapore conference during the shutdown, records show, raising questions of optics, spending and the agency's strained resources.

The FDA is reportedly preparing to add what's known as a "black box" warning to Covid shots by the end of the year, marking a major shift in vaccine oversight.

As consumers find their next grocery obsession in fiber, food and beverage companies are racing to keep up with the trend.

Growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more weight loss medicines near market entry.

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.

That added production capacity for Eli Lilly's obesity pill, orforglipron, is crucial as the company races to file for its approval.

There's hope for U.S. cattle ranchers in the battle to stop the spread of screwworm at a time of decimated herds with the FDA approving a new Merck treatment.

The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.

The billionaire philanthropist and Microsoft cofounder said he saw AI changing lives for the better, despite some overvaluations.

Some public health experts expressed concerns the recommendation could lead to an increase in hepatitis B infections in babies.